Results 101 to 110 of about 14,756 (228)

Prurigo pigmentosa clinically and immunologically mimicking autoimmune bullous disease: A case report. [PDF]

Front Med (Lausanne), 2022
Kita K, Kurokawa I, Hayashi D, Hashimoto T.   +3 more
europepmc   +1 more source

Desenvolupament d'un nou model murí humanitzat de pemfigoide ampul·lar obtingut a partir de cèl·lules mare humanes fol·liculars [PDF]

, 2011
El pemfigoid ampul·lar és una malaltia cutània autoimmune. La majoria dels pacients presenten autoanticossos contra proteïnes de la membrana basal de la pell, concretament en contra de la col·làgena XVII, específicament envers el epítop immunodominant, l'
Martínez Escala, MªEstela, Pascual Angulo, Gloria, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +3 more
core  

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

Brain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan, Arsal Khan, Kuldeep Dalpat Rai, Anzel Saeed, Harsh Kumar, Aneesh Kumar Sangtiani, Tehreem Fatima, Muhammad Tanveer Alam, Faiza Rajput, Sakshi Chawla, Hussain Haider Shah, Humaira Kalam   +11 more
wiley   +1 more source

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset. [PDF]

Front Immunol, 2022
Russo R, Gasparini G, Cozzani E, D'Agostino F, Parodi A.   +4 more
europepmc   +1 more source

Therapy of autoimmune bullous diseases

Therapeutics and Clinical Risk Management, 2007
Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions.
openaire   +3 more sources

Combined Use of Botulinum Toxin A and Profhilo for Upper Face Rejuvenation: A Randomized Clinical Trial

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Hyaluronic acid (HA) and Botulinum toxin A (BTX‐A) treatments are highly regarded for their effectiveness in facial rejuvenation. Aim To investigate whether adding Profhilo enhances the effects of BTX‐A for frontal skin rejuvenation.
Zahra Saffarian, Amirhossein Rahimnia, Ala Ehsani, Kamran Balighi, Amirhoushang Ehsani, Zahra Razavi, Mina Koohian Mohammadabadi, Faezeh khorasanizadeh, Ghazal Ghaffarzadeh, Parvaneh Hatami   +9 more
wiley   +1 more source

Two cases of childhood linear immunoglobulin A bullous dermatosis following multivisceral transplant: A case report

SAGE Open Medical Case Reports
Childhood linear immunoglobulin A bullous dermatosis is a well-recognized autoimmune blistering dermatosis that can be idiopathic, drug-induced, secondary to autoimmune diseases, malignancies, infections, or gastrointestinal diseases including ...
Adam C Yu, Airiss R Chan, Kerry Wong, Kirsten Walker, Loretta Fiorillo   +4 more
doaj   +1 more source

Practical dermatology [PDF]

, 2006
DERMATOLOGYSKIN DISEASESКОЖНЫЕ БОЛЕЗНИМЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИПРАКТИЧЕСКАЯ ДЕРМАТОЛОГИЯRecommendations include tests, clinical tasks and practical skills in dermatology that are used as during practical classes as at the ...
Adaskevich, V. P., Katina, M. A., Valles-Kazlouskaya, V. V.   +2 more
core  

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic non-inferiority randomised controlled trial [PDF]

, 2017
Background: Bullous pemphigoid (BP) is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline conveys acceptable short-term blister control whilst conferring long-term safety advantages ...
A Anstey, A Carmichael, A Lloyd Lavery, A M Layton, A Omerod, Adam Ferguson, Adzura Azam, Alex Waters, Andrew Ilchyshyn, Andrew J Nunn, Andrew Wright, Anna Chapman, B Walker, Bastuji-Garin, Bratton, Brick, C Barnard, C Günthert, C Thomas, Chalmers, Chalmers, Chris Bower, Chris Lovell, D'Agostino, David Gawkrodger, Diane Whitham, E Bröcker, E Veysey, Emilia Duarte-Williamson, Enno Schmidt, F Craig, Feliciani, Fenella Wojnarowska, Fiona Antony, Fivenson, G Patel, G Wong, Goon, Gudula Kirtschig, H Bell, H Malhomme, H Santander, Hofmann, Hywel C Williams, Indre Verpetinske, Ingrid Salvary, J Adams, J English, J Ingram, J Ravenscroft, J Wee, James Mason, Jane Sterling, Joanne R Chalmers, Joly, Joly, Joly, K Davies, K Hussain, K Steinbrink, Karen Gibbon, Karen Harman, Kathy Taghipour, Kirtschig, Langan, Lever, Lloyd-Lavery, M G S Dunnill, M Sticherling, M Vatve, M Walsh, M Westmoreland, Margaret Childs, Marinella Nik, Meijer, Monk, Murrell, N Hepburn, N J Levell, N van Beek, Offen, P J Hampton, R Ellis, R Gläser, R Groves, R Hügel, R R Coelho, R Rallan, R Wachsmuth, Riond, Robert Charles-Holmes, Roujeau, S Blackford, S Wahie, Sam Gibbs, Savin, Schmidt, Schulze, Shernaz Walton, Sobocinski, Taghipour, Taghipour, Thomas Luger, Thomas R Godec, V Akhras, V Lewis, V Venning, Venning, Walter Bottomley   +108 more
core   +4 more sources

Ultrastructural immunocytochemistry of autoimmune bullous diseases

Australasian Journal of Dermatology, 2002
SUMMARYAdvanced immunopathological assays have been developed to elucidate the pathophysiology and provide more precise nosological definitions of the immunobullous diseases. Forty‐seven patients suffering from autoimmune bullous diseases (intra‐ or subepidermal) were studied by immunoelectron microscopy (direct and indirect).
Karpouzis, A., Vamvassakis, E., Stavrianeas, N., Koumantaki-Mathioudaki, E., Karpouzi, M., Vareltzides, A.   +5 more
openaire   +3 more sources